Percuflex Helical Ureteral Stents Significantly Reduce Patient Analgesic Requirements Compared to Control Stents

Chew, Ben H.; Rebullar, Karla; Harriman, David; McDougall, Elspeth M.; Paterson, Ryan F.; Lange, Dirk

doi:10.1089/end.2017.0349

Cited by 11 publications

(8 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Fourth, we used one type of ureteral stent. The type of ureteral stent may affect stent‐related symptoms; therefore, we standardized the stent type . However, we consider that we should also investigate the effect of ureteral stent diameter on urinary symptoms using other types of ureteral stents.…”

Section: Discussionmentioning

confidence: 99%

“…The type of ureteral stent may affect stent-related symptoms; therefore, we standardized the stent type. [25][26][27] However, we consider that we should also investigate the effect of ureteral stent diameter on urinary symptoms using other types of ureteral stents. Future studies should involve randomization and re-evaluation using the USSQ and standardize the stent indwelling time.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Effect of ureteral stent diameter on ureteral stent‐related symptoms

Taguchi

Yoshida

Sugi

et al. 2019

LUTS

View full text Add to dashboard Cite

Objective This study investigated the correlation between ureteral stent diameter and stent‐related symptoms. Methods This study evaluated 17 patients (53 [74.6%] men, 18 [25.4%] women; mean [±SD] age 59.3 ± 14.2 years) who underwent ureteral stent placement before ureteroscopic lithotripsy (URSL) and in whom the ureteral stent tail was positioned inside the bladder without crossing the midline. All stents were Inlay Optima stents. Stent diameter (6 or 4.7 Fr) and length (24 or 26 cm) were chosen at the surgeon's discretion. Patients were classified into two groups (Group 1, 6‐Fr stent; Group 2, 4.7‐Fr stent). Urinary symptoms before insertion of the ureteral stents and the day before URSL were assessed using the International Prostate Symptom Score (IPSS) and Overactive Bladder Symptom Score (OABSS). In addition, patient background and changes in the IPSS and OABSS were compared. Factors affecting ureteral stent‐related symptoms were evaluated using multivariate analysis. Results Compared with Group 2, Group 1 had a worse total IPSS (P = 0.02), as well as intermittency (P = 0.009), urgency (P = 0.008), voiding symptoms (Q1 + Q3 + Q5 + Q6; P = 0.046), and storage symptoms (Q2 + Q4 + Q7; P = 0.017) subscores on the IPSS, total OABSS (P = 0.045) and OABSS urgency subscore (P = 0.002). Multivariate analysis revealed that stent diameter was significantly associated with total IPSS (P = 0.007) and OABSS (P = 0.036). Conclusion This is the first study to show that larger‐diameter ureteral stents induce significantly worse urinary symptoms. Ureteral stents with smaller diameters are recommended to improve ureteral stent‐related symptoms.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Effect of ureteral stent diameter on ureteral stent‐related symptoms

Taguchi

Yoshida

Sugi

et al. 2019

LUTS

View full text Add to dashboard Cite

show abstract

“…Common type of stents include metallic stents 5,16,17 and polymeric stents. [27][28][29][30][31][32][33][34][35][36]…”

Section: Innovation Driven By Patients' Health-related Quality Of Lifmentioning

confidence: 99%

“…Stents augmented with metal wires, shaped into spiral design showed superior flow and drainage. 27 To overcome bladder irritation in patients with ureteric stents, loops of polymer were incorporated instead of the classical pigtail at the distal end of the double-J stents. It was thought that this new "tail stent" would decrease bladder irritation.…”

Section: Polymeric Stents and Their Clinical Usementioning

confidence: 99%

<p>Strategies to Improve Patient Outcomes and QOL: Current Complications of the Design and Placements of Ureteric Stents</p>

Ramachandra

Mosayyebi²,

Carugo³

et al. 2020

RRU

View full text Add to dashboard Cite

Ureteric stents have played a vital role in relieving urinary obstruction in many urological conditions. Although they are extremely successful, stents have been associated with complications and reduced patients' health-related quality of life (HRQoL). There are many factors that may affect the quality and longevity of stents. In this review, we have highlighted the journey and innovation of ureteric stents through the modern day. A literature review was conducted to identify relevant articles over the last 20 years. There is a plethora of evidence with various indications for the use of ureteral stents and how they affect QoL. There is still ongoing research to develop the ideal stent with reduced encrustation, one that resists infection and is also comfortable for the patients. Stents made from metal alloys, polymers and biodegradable materials have unique properties in their own right but also have certain deficiencies. These have been discussed along with an overview of newly developed stents. Certain pharmacological adjuncts have also been highlighted that may be useful to improve patient's tolerance to stents. In summary, this paper describes the features of the different types of stents and the problems that are frequently encountered, including effect on patients' HRQoL and financial burden to healthcare providers.

show abstract

“…Chew and associates [91] recently reported on a new design concept for ureteral stents. They evaluated pain scores in 15 patients that had a Percuflex Helical™ stent inserted and compared them with a historical patient group, stented with a standard Percuflex™ stent (Boston Scientific, MA, USA).…”

Section: Developments In Improving Stent Characteristicsmentioning

confidence: 99%

Ureteral stents in urolithiasis

Beysens

Tailly

2018

Asian Journal of Urology

View full text Add to dashboard Cite

Ever since the ureteral stent design was fitted with a curl on both sides to prevent it from migrating up or down the ureter some 40 years ago, its use has gained tremendous momentum, aiding in the rise and evolution of endourology and has confidently kept its place in modern time urology. Over the past four decades, several designs, coating and biomaterials have been developed, trying to reduce infection, encrustation and other stent related symptoms. As the ideal stent has not yet been discovered, different ways of helping patients with their complaints have been researched. This review will cover these aspects of stent use in urolithiasis.

show abstract

Percuflex Helical Ureteral Stents Significantly Reduce Patient Analgesic Requirements Compared to Control Stents

Abstract: Patients who received a Percuflex Helical ureteral stent required significantly fewer analgesics than those who received a Percuflex stent and both had equivalent pain scores.

Cited by 11 publications

References 13 publications

Effect of ureteral stent diameter on ureteral stent‐related symptoms

Effect of ureteral stent diameter on ureteral stent‐related symptoms

<p>Strategies to Improve Patient Outcomes and QOL: Current Complications of the Design and Placements of Ureteric Stents</p>

Ureteral stents in urolithiasis

Contact Info

Product

Resources

About